Rock Springs Capital Management LP - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 117 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$57,535,163
+22.1%
1,820,7330.0%1.54%
+37.5%
Q2 2023$47,102,363
+9.2%
1,820,733
+1.4%
1.12%
+8.9%
Q1 2023$43,133,507
+23.2%
1,795,7330.0%1.03%
+22.1%
Q4 2022$35,016,794
-7.2%
1,795,7330.0%0.84%
-13.4%
Q3 2022$37,728,000
+12.9%
1,795,733
+4.5%
0.97%
+0.1%
Q2 2022$33,427,000
-8.9%
1,717,733
+3.1%
0.97%
+5.3%
Q1 2022$36,690,000
+49.5%
1,666,208
+8.3%
0.92%
+63.0%
Q4 2021$24,544,000
-19.2%
1,538,814
+0.9%
0.57%
-11.3%
Q3 2021$30,390,000
+15.4%
1,525,623
+0.1%
0.64%
+22.6%
Q2 2021$26,345,000
-11.5%
1,523,723
+1.4%
0.52%
-19.8%
Q1 2021$29,785,000
+14.0%
1,502,800
+0.4%
0.65%
+17.3%
Q4 2020$26,129,000
+2.1%
1,496,525
+12.7%
0.55%
-14.6%
Q3 2020$25,583,000
-0.4%
1,327,614
+0.6%
0.65%
-7.9%
Q2 2020$25,685,000
+47.6%
1,319,910
+6.2%
0.70%
-2.1%
Q1 2020$17,402,000
-43.0%
1,243,000
-0.2%
0.72%
-25.4%
Q4 2019$30,527,000
+284.1%
1,245,000
+57.6%
0.96%
+204.4%
Q3 2019$7,948,000790,0480.32%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 6,470,392$204,464,38713.58%
NEA Management Company, LLC 2,186,243$69,085,2795.34%
TANG CAPITAL MANAGEMENT LLC 1,137,107$35,932,5815.07%
BOONE CAPITAL MANAGEMENT LLC 389,791$12,317,3963.89%
Highlander Partners, L.P. 122,980$3,886,1683.84%
BVF INC/IL 4,370,024$138,092,7583.72%
Prosight Management, LP 353,508$11,170,8533.54%
Novo Holdings A/S 1,500,000$47,400,0003.50%
Nicholas Investment Partners, LP 1,199,366$37,899,9662.83%
Eventide Asset Management 3,958,579$125,091,0972.25%
View complete list of MIRUM PHARMACEUTICALS INC shareholders